TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
KYTX

Kyverna Therapeutics, Inc.

Healthcare · Biotechnology

7.00$ +2.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Kyverna Therapeutics, Inc. (KYTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 64.2% of the shares are freely tradable; institutional investors hold 74.3%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 74.3%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 7.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 64.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 16.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 62Mio.

Largest Shareholders

Institutions

Institutions KYTX
Name Stake (%) Shares Change (%) Date
GordonMD Global Investments LP 6.86 4,244,818 +0.0 06/30/2026
Bain Capital Life Sciences Investors, LLC 5.03 3,110,000 +0.0 03/31/2026
AIGH Capital Management, LLC 4.52 2,795,797 +39.8 06/30/2026
Deerfield Management Co 3.23 2,000,000 +0.0 03/31/2026
Vanguard Capital Management, LLC 2.88 1,783,342 +0.0 03/31/2026
T. Rowe Price Associates, Inc. 2.51 1,555,287 -11.8 03/31/2026
Balyasny Asset Management LLC 1.82 1,125,321 +14.7 03/31/2026

Funds

Funds KYTX
Name Stake (%) Shares Change (%) Date
MEDICAL BioHealth EUR Acc 2.85 1,762,995 +16.5 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.27 1,403,697 +0.0 07/31/2026
iShares Russell 2000 ETF 1.71 1,057,516 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?